Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


21.10.2019

1 Biochem Biophys Res Commun
3 Blood
1 Genes Chromosomes Cancer
2 Int J Hematol
1 J Biol Chem
2 J Pediatr Hematol Oncol
2 Leuk Lymphoma
5 Leukemia
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. ZHOU Z, Liu T, Zhang J
    Morphine activates blast-phase chronic myeloid leukemia cells and alleviates the effects of tyrosine kinase inhibitors.
    Biochem Biophys Res Commun. 2019 Oct 12. pii: S0006-291X(19)31956.
    PubMed     Text format     Abstract available


    Blood

  2. SCHMIEGELOW K
    Yet another susceptibility variant for ALL: what's next?
    Blood. 2019;133:628-629.
    PubMed     Text format    

  3. BULLINGER L
    IDH2 inhibition: another piece to the puzzle.
    Blood. 2019;133:625-626.
    PubMed     Text format    

  4. SMITH CC
    Roman warfare: targeting of support cells in AML.
    Blood. 2019;133:506-507.
    PubMed     Text format    


    Genes Chromosomes Cancer

  5. TERUI K, Toki T, Taga T, Iwamoto S, et al
    Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
    Genes Chromosomes Cancer. 2019 Oct 13. doi: 10.1002/gcc.22816.
    PubMed     Text format     Abstract available


    Int J Hematol

  6. DESCHNER M, Phua C, Saini L, Xenocostas A, et al
    Muscle aches and pains: do I have leukemia?
    Int J Hematol. 2019 Oct 14. pii: 10.1007/s12185-019-02746.
    PubMed     Text format     Abstract available

  7. YANADA M, Takami A, Mizuno S, Mori J, et al
    Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
    Int J Hematol. 2019 Oct 14. pii: 10.1007/s12185-019-02759.
    PubMed     Text format     Abstract available


    J Biol Chem

  8. SANDOVAL JE, Huang YH, Muise A, Goodell MA, et al
    Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
    J Biol Chem. 2019;294:4898-4910.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  9. MEHRVAR N, Abolghasemi H, Rezvany MR, Akbari ME, et al
    Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C.
    J Pediatr Hematol Oncol. 2019 Oct 14. doi: 10.1097/MPH.0000000000001613.
    PubMed     Text format     Abstract available

  10. DE AZEVEDO AC, Matsuda E, Cervellini JY, Prandi LR, et al
    Early Mortality in Children and Adolescents with Acute Promyelocytic Leukemia: Experience of the Boldrini Children's Center.
    J Pediatr Hematol Oncol. 2019 Oct 14. doi: 10.1097/MPH.0000000000001601.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  11. ZHANG P, Ruan J, Weng W, Tang Y, et al
    Overexpression of SET and MYND domain-containing protein 2 (SMYD2) is associated with poor prognosis in pediatric B lineage acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 Oct 15:1-8. doi: 10.1080/10428194.2019.1675875.
    PubMed     Text format     Abstract available

  12. MELEVEEDU KS, Chen D, Nadiminti K, Sidiqi H, et al
    PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.
    Leuk Lymphoma. 2019 Oct 12:1-4. doi: 10.1080/10428194.2019.1675880.
    PubMed     Text format    


    Leukemia

  13. ALANAZI B, Munje CR, Rastogi N, Williamson AJK, et al
    Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0596.
    PubMed     Text format     Abstract available

  14. FURSTENAU M, Bahlo J, Fink AM, Lange E, et al
    Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0597.
    PubMed     Text format    

  15. QUIST-PAULSEN P, Toft N, Heyman M, Abrahamsson J, et al
    T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0598.
    PubMed     Text format     Abstract available

  16. CICCONI L, Platzbecker U, Avvisati G, Paoloni F, et al
    Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0589.
    PubMed     Text format    

  17. WU Z, Sun H, Liu W, Zhu H, et al
    Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0594.
    PubMed     Text format    


    PLoS One


  18. Retraction: Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1.
    PLoS One. 2019;14:e0224304.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: